CN105524162A - 使用改进的溶剂-清洁剂方法进行病毒灭活 - Google Patents
使用改进的溶剂-清洁剂方法进行病毒灭活 Download PDFInfo
- Publication number
- CN105524162A CN105524162A CN201511015603.XA CN201511015603A CN105524162A CN 105524162 A CN105524162 A CN 105524162A CN 201511015603 A CN201511015603 A CN 201511015603A CN 105524162 A CN105524162 A CN 105524162A
- Authority
- CN
- China
- Prior art keywords
- virus
- mixture
- insulation
- protein
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (13)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42351210P | 2010-12-15 | 2010-12-15 | |
US61/423,512 | 2010-12-15 | ||
CN201180067642.8A CN103370072B (zh) | 2010-12-15 | 2011-12-14 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180067642.8A Division CN103370072B (zh) | 2010-12-15 | 2011-12-14 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105524162A true CN105524162A (zh) | 2016-04-27 |
CN105524162B CN105524162B (zh) | 2021-04-27 |
Family
ID=45476616
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511015603.XA Active CN105524162B (zh) | 2010-12-15 | 2011-12-14 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
CN201180067642.8A Active CN103370072B (zh) | 2010-12-15 | 2011-12-14 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180067642.8A Active CN103370072B (zh) | 2010-12-15 | 2011-12-14 | 使用改进的溶剂-清洁剂方法进行病毒灭活 |
Country Status (18)
Country | Link |
---|---|
US (2) | US20120208982A1 (zh) |
EP (2) | EP3495385A1 (zh) |
JP (1) | JP6013360B2 (zh) |
KR (2) | KR101921036B1 (zh) |
CN (2) | CN105524162B (zh) |
AR (1) | AR084301A1 (zh) |
AU (1) | AU2011343811B2 (zh) |
BR (1) | BR112013015113B1 (zh) |
CA (1) | CA2821971A1 (zh) |
CO (1) | CO6761367A2 (zh) |
EA (1) | EA025783B1 (zh) |
IL (1) | IL226926B (zh) |
MX (1) | MX352082B (zh) |
MY (1) | MY161252A (zh) |
NZ (1) | NZ611994A (zh) |
SG (2) | SG10201509994PA (zh) |
TW (1) | TWI557229B (zh) |
WO (1) | WO2012082931A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109022377A (zh) * | 2017-06-12 | 2018-12-18 | 舒泰神(北京)生物制药股份有限公司 | 一种杆状病毒表达系统中杆状病毒的灭活方法 |
CN111050809A (zh) * | 2017-07-10 | 2020-04-21 | 百深公司 | 孵育液体和灭活病毒的方法 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014025771A2 (en) * | 2012-08-06 | 2014-02-13 | Biogen Idec Ma Inc. | Methods and compositions for inactivating enveloped viruses |
TWI641382B (zh) * | 2013-01-31 | 2018-11-21 | 韓美藥品股份有限公司 | 於包含因子vii之組成物中使病毒失活之方法 |
HRP20240222T1 (hr) * | 2013-11-15 | 2024-04-26 | F. Hoffmann - La Roche Ag | Postupci inaktivacije virusa korištenjem ekološki prihvatljivih deterdženata |
DE102015115024A1 (de) * | 2015-09-08 | 2017-03-09 | Schülke & Mayr GmbH | Flüssigkonzentrat für die Konservierung von Kosmetika |
EP3446710A1 (en) * | 2017-08-25 | 2019-02-27 | Glenmark Pharmaceuticals S.A. | Methods of inactivating viral contaminants |
AU2018357917A1 (en) * | 2017-10-30 | 2020-05-07 | Takeda Pharmaceutical Company Limited | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
SG11202009213TA (en) | 2018-03-21 | 2020-10-29 | Baxalta Inc | Separation of vwf and vwf propeptide by chromatographic methods |
AU2020240034A1 (en) * | 2019-03-19 | 2021-08-19 | Amgen Inc. | Alternate detergents for viral inactivation |
EP4072600A1 (en) * | 2019-12-12 | 2022-10-19 | Eli Lilly and Company | Methods for viral inactivation by environmentally compatible detergents |
WO2021197646A1 (de) * | 2020-03-31 | 2021-10-07 | Schülke & Mayr GmbH | Wässrige octenidinhaltige zusammensetzung zur behandlung und/oder prävention einer exazerbation von erkrankungen infolge einer coronavirusinfektion |
WO2022173553A1 (en) * | 2021-02-12 | 2022-08-18 | Siemens Healthcare Diagnostics Inc. | Sample lysis reagent compositions and methods of production and use thereof |
WO2023052556A1 (en) | 2021-09-30 | 2023-04-06 | Ichnos Sciences SA | Methods of inactivating viral contaminants with a mixture of solvent and detergent |
KR102420201B1 (ko) * | 2022-01-17 | 2022-07-13 | 주식회사 유이케미칼 | 인지질 외피 보유 바이러스 사멸기능을 가지는 친환경 방역 조성물 |
CN116272708B (zh) * | 2023-03-16 | 2023-11-14 | 海南医学院 | 一种量子点-抗体复合物微球及其制备方法、应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378208A2 (en) * | 1989-01-13 | 1990-07-18 | The Green Cross Corporation | Production method for protein-containing composition |
CN1120803A (zh) * | 1993-12-17 | 1996-04-17 | 巴克斯特国际有限公司 | 处理体液的方法和装置 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681867B1 (fr) * | 1991-09-26 | 1993-12-31 | Pasteur Merieux Serums Vaccins | Procede de purification du facteur viii et preparations obtenues. |
WO2005099858A1 (en) | 2004-04-13 | 2005-10-27 | Sangart, Inc. | Methods and compositions for simultaneously isolating hemoglobin from red blood cells and inactivating viruses |
-
2011
- 2011-12-14 JP JP2013544750A patent/JP6013360B2/ja active Active
- 2011-12-14 KR KR1020187011829A patent/KR101921036B1/ko active IP Right Grant
- 2011-12-14 CA CA2821971A patent/CA2821971A1/en not_active Abandoned
- 2011-12-14 US US13/325,858 patent/US20120208982A1/en not_active Abandoned
- 2011-12-14 CN CN201511015603.XA patent/CN105524162B/zh active Active
- 2011-12-14 NZ NZ61199411A patent/NZ611994A/en unknown
- 2011-12-14 EP EP18208034.1A patent/EP3495385A1/en active Pending
- 2011-12-14 CN CN201180067642.8A patent/CN103370072B/zh active Active
- 2011-12-14 SG SG10201509994PA patent/SG10201509994PA/en unknown
- 2011-12-14 WO PCT/US2011/064960 patent/WO2012082931A1/en active Application Filing
- 2011-12-14 EP EP11808044.9A patent/EP2651421A1/en not_active Withdrawn
- 2011-12-14 AU AU2011343811A patent/AU2011343811B2/en active Active
- 2011-12-14 BR BR112013015113-7A patent/BR112013015113B1/pt active IP Right Grant
- 2011-12-14 EA EA201390856A patent/EA025783B1/ru not_active IP Right Cessation
- 2011-12-14 KR KR1020137018323A patent/KR101854310B1/ko active Application Filing
- 2011-12-14 SG SG2013046230A patent/SG191184A1/en unknown
- 2011-12-14 MY MYPI2013002236A patent/MY161252A/en unknown
- 2011-12-14 MX MX2013006832A patent/MX352082B/es active IP Right Grant
- 2011-12-15 TW TW100146427A patent/TWI557229B/zh active
- 2011-12-15 AR ARP110104694A patent/AR084301A1/es not_active Application Discontinuation
-
2013
- 2013-06-13 IL IL226926A patent/IL226926B/en active IP Right Grant
- 2013-07-11 CO CO13165222A patent/CO6761367A2/es unknown
-
2016
- 2016-12-22 US US15/389,291 patent/US20170327559A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0378208A2 (en) * | 1989-01-13 | 1990-07-18 | The Green Cross Corporation | Production method for protein-containing composition |
CN1120803A (zh) * | 1993-12-17 | 1996-04-17 | 巴克斯特国际有限公司 | 处理体液的方法和装置 |
Non-Patent Citations (5)
Title |
---|
DICHTELÜLLER 等: "Robustness of solvent/detergent treatment of plasma derivatives:a data collection from Plasma Protein Therapeutics association member companies", 《TRANSFUSION》 * |
ROBERTS PETER L.: "Virus inactivation by solvent/detergent treatment using Triton X-100 in a high purity factor VIII", 《BIOLOGICALS》 * |
ROBERTS 等: "Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate", 《BIOLOGICALS》 * |
何广发 等: "冻干人凝血因子VIII制剂的S/D处理及其理化分析", 《中国生物制品学杂志》 * |
王剑锋 等: "S/D法灭活血液制剂中脂包膜病毒效果验证的研究", 《微生物学免疫学进展》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109022377A (zh) * | 2017-06-12 | 2018-12-18 | 舒泰神(北京)生物制药股份有限公司 | 一种杆状病毒表达系统中杆状病毒的灭活方法 |
CN111050809A (zh) * | 2017-07-10 | 2020-04-21 | 百深公司 | 孵育液体和灭活病毒的方法 |
CN111050809B (zh) * | 2017-07-10 | 2021-12-24 | 武田药品工业株式会社 | 孵育液体和灭活病毒的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103370072B (zh) | 2016-02-03 |
BR112013015113B1 (pt) | 2023-01-31 |
EA201390856A1 (ru) | 2013-12-30 |
SG10201509994PA (en) | 2016-01-28 |
US20170327559A1 (en) | 2017-11-16 |
MX352082B (es) | 2017-11-08 |
US20120208982A1 (en) | 2012-08-16 |
EA025783B1 (ru) | 2017-01-30 |
EP3495385A1 (en) | 2019-06-12 |
MY161252A (en) | 2017-04-14 |
JP2014501247A (ja) | 2014-01-20 |
CO6761367A2 (es) | 2013-09-30 |
EP2651421A1 (en) | 2013-10-23 |
JP6013360B2 (ja) | 2016-10-25 |
TW201233805A (en) | 2012-08-16 |
TWI557229B (zh) | 2016-11-11 |
WO2012082931A1 (en) | 2012-06-21 |
KR101921036B1 (ko) | 2018-11-21 |
AU2011343811B2 (en) | 2015-04-16 |
CN103370072A (zh) | 2013-10-23 |
IL226926B (en) | 2020-05-31 |
AR084301A1 (es) | 2013-05-08 |
CA2821971A1 (en) | 2012-06-21 |
KR101854310B1 (ko) | 2018-05-04 |
BR112013015113A2 (pt) | 2018-11-06 |
KR20130137663A (ko) | 2013-12-17 |
KR20180049160A (ko) | 2018-05-10 |
AU2011343811A1 (en) | 2013-05-09 |
MX2013006832A (es) | 2014-01-31 |
SG191184A1 (en) | 2013-07-31 |
CN105524162B (zh) | 2021-04-27 |
NZ611994A (en) | 2015-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103370072B (zh) | 使用改进的溶剂-清洁剂方法进行病毒灭活 | |
Johnson et al. | Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates | |
Barderas et al. | Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins | |
YAMAGUSH13 | Development of an antivenom against toxins of Lonomia obliqua caterpillars | |
CN110330563A (zh) | 用于出血性疾病治疗的修饰的丝氨酸蛋白酶抑制剂 | |
EP0774261A2 (de) | Verwendung von von Willebrand-Faktor und pharmazeutische Zubereitung | |
US8293242B2 (en) | Ultra-high yield of alpha-1-anti-trypsin | |
Antignus et al. | A phosphorus-containing fraction associated with antiviral activity in Nicotiana spp. carrying the gene for localization of TMV infection | |
AU2015204304B2 (en) | Viral Inactivation Using Improved Solvent-Detergent Method | |
JP3024073B2 (ja) | タンパク質中のウイルスを不活性化する方法 | |
Eis-Hübinger et al. | Parvovirus B19 DNA contamination in coagulation factor VIII products | |
Mazurier et al. | In vitro evaluation of a very‐high‐purity, solvent/detergent‐treated, von Willebrand factor concentrate | |
US20200248162A1 (en) | Mutated factor x polypeptides and uses thereof for the treatment of haemophilia | |
Highsmith et al. | Iodine-mediated inactivation of lipid-and nonlipid-enveloped viruses in human antithrombin III concentrate | |
EP3747903A1 (en) | Method and kit for testing potency of immunoglobulin compositions | |
Rieger et al. | Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil | |
Highsmith et al. | Viral inactivation of vesicular stomatitis virus in normal human serum by cross-linked polyvinylpyrrolidone | |
CN109097482A (zh) | 细粒棘球绦虫线粒体nd6基因的应用 | |
Grau-Expósito et al. | Novel Human Lung Tissue Model for the Study of SARS-CoV-2 Entry, Inflammation and New Therapeutics | |
Bencsik | The Importance of the Natural Transmission of Rift Valley Fever Virus for Its Infection in the Mammalian Host | |
Wolf | Preparation and clinical use of a concentrate of human antihaemophilic factor | |
Beaver | The Innate Immune Response to Ectromelia Virus Infection: Early Effector Mechanisms and Cell Types | |
AT404516B (de) | Vorrichtung zur quantifizierung von prothrombin-derivaten | |
BRIGGAMAN et al. | Hill, North Carolina; the* Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and the* Department of Dermatology, University of Kuopio, Kuopio, Finland | |
Kitanaka et al. | Spread of Vaccinia Virus to Cattle Herds, Argentina, 2011 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1225036 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211014 Address after: No. 1, 1-1, sidingmu, Daoxiu Town, Central District, Osaka City, Japan Patentee after: TAKEDA PHARMACEUTICAL Co.,Ltd. Address before: Illinois, USA Patentee before: Baishen Co. Patentee before: BAXALTA GmbH Effective date of registration: 20211014 Address after: Illinois, USA Patentee after: Baishen Co. Patentee after: BAXALTA GmbH Address before: Illinois, USA Patentee before: BAXTER INTERNATIONAL Inc. Patentee before: BAXTER HEALTHCARE S.A. |
|
TR01 | Transfer of patent right |